V105M (p.Val105Met) variant of ALDOB (Fructose-bisphosphate aldolase B)

V105M (p.Val105Met) in ALDOB (Fructose-bisphosphate aldolase B) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.60 / 1. The record also includes population frequency data.

V105M (p.Val105Met) variant details